Clinical Trials Logo

Cognition clinical trials

View clinical trials related to Cognition.

Filter by:

NCT ID: NCT01261182 Completed - Malnutrition Clinical Trials

Targeting School Feeding Programs at Vulnerable Sub-Groups

Start date: n/a
Phase: N/A
Study type: Interventional

School feeding programs provide students meals conditional on school attendance, which can have impacts on school participation, cognition and learning, and nutritional outcomes. Although the literature on impacts of school feeding programs is substantial, high quality studies with evaluation designs that provide causal impact estimates are relatively few. Thus program impacts on educational, cognitive and nutritional outcomes are not well-understood, particularly in a field setting. Nutritional impacts in particular are questionable, which may be a result program design. Most studies provide only small transfers to children and examine average macro-nutrient effects of the transfer on the treated children, thus it is not surprising that detection of nutritional gains has been minimal. This study is a cluster-randomized evaluation of a school feeding program administered by the World Food Programme in the Northern Ugandan Districts of Lira and Pader. The program provides substantially larger food rations than most programs (representing 1/3 of children's daily caloric needs and 99% of iron intake requirements). The key research objectives are: 1. Impact on the treated: Assess the effectiveness of the program at improving nutritional status, education and cognitive and learning outcomes for school-age children, with particular attention to the anemia status of older school-age girls . 2. Impact on untreated but nutritionally vulnerable sub-groups: Assess the effectiveness of the program at reducing anemia prevalence in mothers and younger siblings. 3. Optimal program design: Assess the differential impacts of a program in which children are fed at school compared with one in which they are given dry rations to bring home.

NCT ID: NCT01223404 Completed - Clinical trials for Magnetic Resonance Imaging

Nicotinic Modulation of the Default Network

Start date: October 2010
Phase: N/A
Study type: Interventional

Many disorders where attentional problems are a hallmark, such as Alzheimer's disease and schizophrenia, display abnormal regulation of the so-called default network of resting brain function that maintains internally directed thought when the mind is free to wander. There is indication that nicotine may improve attention by aiding the deactivation of the default network, and this mechanism may be of therapeutic benefit for the above disease states. The current project aims at providing a proof of concept by demonstrating that nicotinic drugs modulate default network function. The nicotinic agonist nicotine is hypothesized to improve attention by facilitating the down-regulation of default network activity, and the nicotinic antagonist mecamylamine is hypothesized to impair attention by impeding the down-regulation of default network activity during attentional task performance.

NCT ID: NCT01164020 Completed - Aging Clinical Trials

Creatine Supplementation and Cognition

Start date: August 2010
Phase: N/A
Study type: Interventional

Resistance training as well as creatine supplementation may be beneficial for cognitive function, such as memory and attention. Therefore, the investigators speculate that resistance training combined with creatine supplementation would promote additive benefits on cognitive function in elderly women.

NCT ID: NCT01126424 Completed - Cognition Clinical Trials

A Study to Compare Two Medications With an Inactive Medication and Look at the Effect on a Person's Mental Ability

SENIOR
Start date: April 2010
Phase: Phase 4
Study type: Interventional

The purpose is to compare solifenacin and oxybutynin with an inactive tablet and assess any potential effects on mental ability.

NCT ID: NCT01108679 Completed - HIV Infections Clinical Trials

Neurocognitive Effects of Buprenorphine Among HIV+ and HIV-Opioid Users

Start date: December 1, 2009
Phase:
Study type: Observational

The purpose of this study is to examine how Buprenorphine, a form of opioid addiction treatment, changes the ability to think and reason among people addicted to opiates, who are either HIV negative or HIV positive. In addition, blood samples will be stored for HIV+ and HIV- individuals who take buprenorphine to study its effect. This study hypothesizes that the HIV positive participants will demonstrate significant improvement in thinking and reasoning ability at 3 and 6 months compared to baseline, but that their thinking and reasoning ability will still be lower than HIV negative participants. This study also hypothesizes the biomarkers in participants' blood samples will be associated with measures of change in thinking and reasoning ability.

NCT ID: NCT01079468 Completed - Cognition Clinical Trials

Cognition in Postoperative Total Hip Arthroplasty and Total Hip Resurfacing Patients

Start date: January 2010
Phase: N/A
Study type: Observational

Transient cognitive changes after surgery may be due to many different factors. It is estimated that between 5-29% of patients undergoing orthopedic surgery experience a transient decline in their cognition. Fat and bone marrow debris embolization can cause cognitive changes if they enter the cerebral circulation in significant numbers. During total hip arthroplasty the placement of the femoral stem leads to a rise in intramedullary pressure which can cause fat and bone marrow debris to embolize into the systemic circulation. Total hip resurfacing arthroplasty avoids entrance into the femoral canal. The purpose of this study is to assess transient cognitive changes after total hip arthroplasty and compare them to patients undergoing total hip resurfacing arthroplasty. We hypothesize that patients undergoing total hip resurfacing arthroplasty will experience less transient cognitive changes due to the avoidance of violating the femoral canal during the procedure.

NCT ID: NCT01073228 Completed - Alzheimer's Disease Clinical Trials

Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease

Start date: April 2010
Phase: Phase 2
Study type: Interventional

This study is being conducted to determine the safety and effect on cognitive function of the investigational medication, EVP-6124, in individuals with mild to moderate probable Alzheimer's disease.

NCT ID: NCT01055418 Completed - Cognition Clinical Trials

Cognitive and Cerebral Blood Flow Effects of Vitamin C

Start date: January 2010
Phase: Phase 4
Study type: Interventional

This investigation is interested in the effects of high dose vitamin C on endothelial function in healthy humans. A high fat meal will be utilized to induce endothelial dysfunction. It is hypothesized that, via antioxidant actions, vitamin C will reverse these effects and in turn improve blood flow- the involvement of nitric oxide suggests that this could extend to cerebral blood flow. This will be monitored by trans cranial doppler flow meter and near infrared spectroscopy.

NCT ID: NCT01044342 Completed - Cognition Clinical Trials

A Healthy Volunteer Study to Evaluate Reversibility of Induced Impairment of Cognition

Start date: December 2009
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine if cognitive impairment induced by scopolamine is reversed using donepezil and/or AZD1446 as compared to placebo, as assessed by electroencephalogram (EEG) measures.

NCT ID: NCT00989040 Completed - Cognition Clinical Trials

Impact of Neuropathic Post-Zosterian Pain on the Cognition

Start date: March 2009
Phase: Phase 1
Study type: Observational

Pain is defined as a sensorial and emotional phenomenon and lead consequences on the cognition. These consequences could be increased with usual treatment. So the aim of this study is to explore these cognitive consequences.